Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smyth

Showing results (231-240 of 294) with videos related to

Pageof 30
Sort By:
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
Cancer Treatment Reports|January 1, 1981
Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical studyP J Dady, G A Taylor, J F Muindi, et al.
British Journal of Cancer|November 1, 1990
Prognostic factors for survival in soft tissue sarcomaJ N el-Jabbour, S S Akhtar, G R Kerr, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1994
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell linesS P Langdon, G L Hirst, E P Miller, et al.
British Journal of Cancer|August 1, 1995
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumoursH Gabra, L Taylor, B B Cohen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activityM E O'Brien, D M Eccles, S G Allen, et al.
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancerOlusola O Faluyi, Charlie Gourley, John F Smyth, et al.
Cancer Research|March 1, 1996
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosisH Gabra, J E Watson, K J Taylor, et al.
Biochemical Pharmacology|December 12, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteinsJeffrey Cummings, Noam Zelcer, John D Allen, et al.
Pageof 30

Showing results (231-240 of 294) with videos related to

Sort By:
Pageof 30
Cancer Research|July 1, 1989
Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and miceJ Cummings, J A Double, M C Bibby, et al.
Cancer Treatment Reports|January 1, 1981
Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical studyP J Dady, G A Taylor, J F Muindi, et al.
British Journal of Cancer|November 1, 1990
Prognostic factors for survival in soft tissue sarcomaJ N el-Jabbour, S S Akhtar, G R Kerr, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1994
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell linesS P Langdon, G L Hirst, E P Miller, et al.
British Journal of Cancer|August 1, 1995
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumoursH Gabra, L Taylor, B B Cohen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activityM E O'Brien, D M Eccles, S G Allen, et al.
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2011
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancerOlusola O Faluyi, Charlie Gourley, John F Smyth, et al.
Cancer Research|March 1, 1996
Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosisH Gabra, J E Watson, K J Taylor, et al.
Biochemical Pharmacology|December 12, 2003
Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteinsJeffrey Cummings, Noam Zelcer, John D Allen, et al.
Pageof 30